Hexagon Capital Partners LLC Bio Rad Laboratories, Inc. Transaction History
Hexagon Capital Partners LLC
- $546 Million
- Q4 2024
A detailed history of Hexagon Capital Partners LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 72 shares of BIO stock, worth $19,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 72
-0.0%
Holding current value
$19,125
Previous $24,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
477Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$510 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$412 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$277 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$259 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$198 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.54B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...